The biggest message we have for our patients is that we understand lung cancer is a scary disease,” Smith said, “but if we ...
As the rates of late-stage lung cancer in nonsmokers rise in Canada, researchers are advocating for increased awareness and screening. According to the Canadian Cancer Society, lung cancer was ...
The AIM-HIGH trial showed significant DFS improvement in high-risk stage 1a to 2a nonsquamous NSCLC patients receiving adjuvant chemotherapy. At 24 months, 96% of chemotherapy patients were alive ...
Please provide your email address to receive an email when new articles are posted on . Guidelines for the management of early-stage non-small cell lung cancer were last published in 2013. The new ...
Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer
CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance maladie du ...
CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, ...
As Tania Rodrigues drove to work one morning in January 2024, something unusual happened with her vision. “All of a sudden, I was looking through a kaleidoscope or perhaps like a fly’s eye,” the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results